RTA certificate dated April 03,2025 attached herewith
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd has submitted a certificate from its Registrar and Transfer Agent (RTA), Venture Capital and Corporate Investments Pvt Ltd, confirming compliance with SEBI's Regulation 74(5) for the fourth quarter and financial year ended March 31, 2025. The RTA certifies that all physical shares received for demat conversion were properly cancelled and that the company records were updated with NSDL and CDSL within 15 days, as required. The stock code is 524636 and ISIN is INE102E01018. The filing is dated April 18, 2025 and signed by Company Secretary Dolly Lakhichand Mandhan. This is a routine quarterly compliance filing, not a business update.
No material impact on shareholders or stock price. This is a standard procedural compliance disclosure confirming smooth processing of share dematerialization requests. Investors can ignore it for investment decisions.